The development of nanocarriers for natural products
- PMID: 38757428
- DOI: 10.1002/wnan.1967
The development of nanocarriers for natural products
Abstract
Natural bioactive compounds from plants exhibit substantial pharmacological potency and therapeutic value. However, the development of most plant bioactive compounds is hindered by low solubility and instability. Conventional pharmaceutical forms, such as tablets and capsules, only partially overcome these limitations, restricting their efficacy. With the recent development of nanotechnology, nanocarriers can enhance the bioavailability, stability, and precise intracellular transport of plant bioactive compounds. Researchers are increasingly integrating nanocarrier-based drug delivery systems (NDDS) into the development of natural plant compounds with significant success. Moreover, natural products benefit from nanotechnological enhancement and contribute to the innovation and optimization of nanocarriers via self-assembly, grafting modifications, and biomimetic designs. This review aims to elucidate the collaborative and reciprocal advancement achieved by integrating nanocarriers with botanical products, such as bioactive compounds, polysaccharides, proteins, and extracellular vesicles. This review underscores the salient challenges in nanomedicine, encompassing long-term safety evaluations of nanomedicine formulations, precise targeting mechanisms, biodistribution complexities, and hurdles in clinical translation. Further, this study provides new perspectives to leverage nanotechnology in promoting the development and optimization of natural plant products for nanomedical applications and guiding the progression of NDDS toward enhanced efficiency, precision, and safety. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
Keywords: nanocarriers; natural products; plant bioactive compounds.
© 2024 Wiley Periodicals LLC.
Similar articles
-
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.Int J Biol Macromol. 2024 Oct;278(Pt 4):135072. doi: 10.1016/j.ijbiomac.2024.135072. Epub 2024 Aug 25. Int J Biol Macromol. 2024. PMID: 39191341 Review.
-
Nanocarriers as Administration Systems of Natural Products.Curr Top Med Chem. 2021;21(26):2365-2373. doi: 10.2174/1568026621666210915121957. Curr Top Med Chem. 2021. PMID: 34525921 Review.
-
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046. Pharm Nanotechnol. 2024. PMID: 37587812 Review.
-
Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.Curr Pharm Des. 2016;22(27):4219-31. doi: 10.2174/1381612822666160620072539. Curr Pharm Des. 2016. PMID: 27323758 Review.
-
The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.Curr Top Med Chem. 2024;24(8):686-721. doi: 10.2174/0115680266287101240214071718. Curr Top Med Chem. 2024. PMID: 38409730 Review.
Cited by
-
Synthesis and preliminary cytotoxicity evaluation of water soluble pentacyclic triterpenoid phosphonates.Sci Rep. 2024 Nov 14;14(1):28031. doi: 10.1038/s41598-024-76816-w. Sci Rep. 2024. PMID: 39543237 Free PMC article.
References
FURTHER READING
-
- Chen, J., Han, X., Deng, J., Zhang, J., Li, L., Ni, J., Huang, Y., Xie, X., Chen, S., Ke, L., Gao, X., Wang, W., & Fan, G. (2021). An injectable hydrogel based on phenylboronic acid hyperbranched macromer encapsulating gold nanorods and Astragaloside IV nanodrug for myocardial infarction. Chemical Engineering Journal, 413, 127423. https://doi.org/10.1016/j.cej.2020.127423
-
- Chen, M.‐H., Gu, Y.‐Y., Zhang, A. L., Sze, D. M., Mo, S.‐L., & May, B. H. (2021). Biological effects and mechanisms of matrine and other constituents of Sophora flavescens in colorectal cancer. Pharmacological Research, 171, 105778. https://doi.org/10.1016/j.phrs.2021.105778
-
- Chen, N., Sun, J., Zhu, Z., Cribbs, A. P., & Xiao, B. (2022). Edible plant‐derived nanotherapeutics and nanocarriers: Recent progress and future directions. Expert Opinion on Drug Delivery, 19(4), 409–419. https://doi.org/10.1080/17425247.2022.2053673
-
- Chen, T., Zhu, Z., Du, Q., Wang, Z., Wu, W., Xue, Y., Wang, Y., Wu, Y., Zeng, Q., Jiang, C., Shen, C., Liu, L., Zhu, H., & Liu, Q. (2021). A skin lipidomics study reveals the therapeutic effects of tanshinones in a rat model of acne. Frontiers in Pharmacology, 12, 675659. https://doi.org/10.3389/fphar.2021.675659
-
- Chen, X., Liu, Q., Yang, J., Kan, M., Jin, R., Pu, T., Yang, Y., Xing, T., Meng, X., & Zang, H. (2021). Eleutheroside B‐loaded poly (lactic‐co‐glycolic acid) nanoparticles protect against renal fibrosis via Smad3‐dependent mechanism. Phytotherapy Research, 35(11), 6401–6416. https://doi.org/10.1002/ptr.7293
REFERENCES
-
- Abbas, H., Sayed, N. S. E., Youssef, N. A. H. A., M. E. Gaafar, P., Mousa, M. R., Fayez, A. M., & Elsheikh, M. A. (2022). Novel luteolin‐loaded chitosan decorated nanoparticles for brain‐targeting delivery in a sporadic Alzheimer's disease mouse model: Focus on antioxidant, anti‐inflammatory, and amyloidogenic pathways. Pharmaceutics, 14(5), 1003. https://doi.org/10.3390/pharmaceutics14051003
-
- Abbaszadeh, S., Rashidipour, M., Khosravi, P., Shahryarhesami, S., Ashrafi, B., Kaviani, M., & Moradi Sarabi, M. (2020). Biocompatibility, cytotoxicity, antimicrobial and epigenetic effects of novel chitosan‐based quercetin nanohydrogel in human cancer cells. International Journal of Nanomedicine, 15, 5963–5975. https://doi.org/10.2147/IJN.S263013
-
- Abdel‐Halim, E. S., El‐Rafie, M. H., & Al‐Deyab, S. S. (2011). Polyacrylamide/guar gum graft copolymer for preparation of silver nanoparticles. Carbohydrate Polymers, 85(3), 692–697. https://doi.org/10.1016/j.carbpol.2011.03.039
-
- Abenavoli, L., Izzo, A. A., Milić, N., Cicala, C., Santini, A., & Capasso, R. (2018). Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research, 32(11), 2202–2213. https://doi.org/10.1002/ptr.6171
-
- Aboushanab, A. R., El‐Moslemany, R. M., El‐Kamel, A. H., Mehanna, R. A., Bakr, B. A., & Ashour, A. A. (2023). Targeted fisetin‐encapsulated β‐cyclodextrin nanosponges for breast cancer. Pharmaceutics, 15(5), 1480. https://doi.org/10.3390/pharmaceutics15051480
Publication types
MeSH terms
Grants and funding
- 2022YJZX-LN18/Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases
- 2022YJZX-LN20/Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases
- 2023YJZX-LN08/Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases
- 2023YJZX-LN10/Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases
LinkOut - more resources
Full Text Sources